Focus Area: Synthetic Biology
186 Results for 'Synthetic Biology'
- Technologies (16)
- Team (0)
- News (138)
- Events (0)
- Multimedia (32)
- Publications (0)
- Jobs (0)
Technologies 16
-
Circe: Tailored Fats for Food Applications
The Problem Human society relies on an inefficient, carbon-intensive linear manufacturing process in which products are created, used, and discarded. This system produces large amounts of waste at every step that is not captured and reused, causing a significant loss of value and damage to the environment. Food production is responsible for one quarter of... -
Circe: Transforming Greenhouse Gases into Biodegradable Products
Our society is built upon cheap, widely available petrochemicals. Beyond gasoline and other fuels, petrochemicals are primary components of many of the objects in our everyday lives, including clothing, cosmetics, electronics, packaging, paint, floors, cars, and furniture. The vast majority of these products do not biodegrade in the environment and are not recycled, and the... -
eRNA: Controlled Enzymatic RNA Oligonucleotide Synthesis
Synthetic RNA oligonucleotides designed as specific successions of the four nucleobases A, U, G, and C that mimic naturally occurring RNA species are the key components of diverse RNA-based therapies. These include RNA therapeutics that can partially or completely turn off the expression of disease-causing genes (antisense and interfering RNAs), help replace or supplement dysfunctional... -
DNA Data Storage
The genetic material DNA has garnered considerable interest as a medium for digital information storage because its density and durability are superior to those of existing silicon-based storage media. For example, DNA is at least 1000-fold more dense than the most compact solid-state hard drive and at least 300-fold more durable than the most stable... -
Synthetic AAV Capsids for Advanced Gene Therapy
The protein shell (capsid) of Adeno-associated viruses (AAV) are presently the most promising delivery vehicles for various in vivo gene therapies. AAVs are non-pathogenic and, through past engineering efforts, have become safe due to their inability to integrate into and damage the genome of target cells. Rather, the delivered DNA containing a therapeutic gene of... -
INSPECTR™: Direct-to-Consumer Molecular Diagnostic
Molecular diagnostics is the fastest growing segment of the global in vitro diagnostics market. There remains a gap, however, in providing this technology directly to consumers in a format that is as cost effective and as simple to use as a lateral flow immunoassay, like glucose and pregnancy tests. Scientists at the Wyss Institute have...
News 138
Multimedia 32
-
Video/AnimationCirce: Using Microbes to Make Biodegradable ProductsCurrent manufacturing methods release harmful greenhouse gases and pollution, and many of the products produced do not biodegrade, damaging our ecosystems even further. What if we could turn greenhouse gases into biodegradable products? Researchers at the Wyss Institute are using synthetic biology to make this a reality. Credit: Wyss Institute at Harvard University -
Video/AnimationGeorge Church in the Xchange: Curiosity-Driven Science, Technology, And SocietyIn this episode of the Xchange, we hear from George Church, a true pioneer of synthetic biology and genomics. George will share possible silver linings of the COVID-19 pandemic, draw parallels between personalized medicine and personalized learning and explore what it means to really think outside of the box. A new virtual interview series from... -
Video/AnimationEnzymatic DNA Synthesis (EDS) for Data StoragePostdoctoral Fellow, Henry Lee, presents a Wyss Institute Validation Project that is developing a sustainable, low-cost approach for writing large amounts of digital information in DNA. This could one day replace current data storage methods, which are energy intensive and use large amounts of nonrenewable resources. Credit: Wyss Institute at Harvard University -
Video/AnimationBeating Back the CoronavirusWhen the coronavirus pandemic forced Harvard University to ramp down almost all on-site operations, members of the Wyss Institute community refocused their teams, and formed new ones, in order to fight COVID-19 on its multiple fronts. These efforts include building new pieces of personal protective equipment that were delivered to frontline healthcare workers, developing new... -
Video/AnimationImproving Canine HealthspanA Wyss Institute technology that can treat multiple age-related diseases is now being developed by Rejuvenate Bio into a treatment for mitral valve disease and other deadly conditions in dogs, with the goal of helping man’s best friend live longer, healthier lives. Credit: Wyss Institute at Harvard University -
Video/AnimationAAV Capsid EngineeringWyss researchers have created a high-throughput platform to generate an Adeno-associated virus 2 (AAV2) library containing 200,000 variants, each carrying a distinct mutation in the virus capsid protein. Their analysis identified capsid changes that enhanced “homing” potential to specific organs in mice and virus viability, as well as a new protein hidden in the capsid-encoding...